Yamashita Health Care Holdings,Inc. (TYO:9265)
3,130.00
-65.00 (-2.03%)
Oct 27, 2025, 1:47 PM JST
TYO:9265 Revenue
Yamashita Health Care Holdings,Inc. had revenue of 15.08B JPY in the quarter ending August 31, 2025, a decrease of -0.69%. This brings the company's revenue in the last twelve months to 64.38B, up 2.65% year-over-year. In the fiscal year ending May 31, 2025, Yamashita Health Care Holdings,Inc. had annual revenue of 64.49B with 4.76% growth.
Revenue (ttm)
64.38B
Revenue Growth
+2.65%
P/S Ratio
0.12
Revenue / Employee
105.03M
Employees
613
Market Cap
7.95B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 31, 2025 | 64.49B | 2.93B | 4.76% |
| May 31, 2024 | 61.56B | 3.36B | 5.77% |
| May 31, 2023 | 58.20B | 3.05B | 5.53% |
| May 31, 2022 | 55.15B | -14.99B | -21.37% |
| May 31, 2021 | 70.13B | 5.47B | 8.46% |
| May 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.48T |
| Otsuka Holdings | 2.40T |
| Astellas Pharma | 1.94T |
| Daiichi Sankyo Company | 1.92T |
| Chugai Pharmaceutical | 1.21T |
| Terumo | 1.04T |
| Olympus | 969.02B |
| HOYA Corporation | 876.09B |